![Josh Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josh Cohen
Gründer bei
AMYLYX PHARMACEUTICALS, INC.
Vermögen: 105 Mio $ am 30.09.2026
Profil
Mr. Joshua B. Cohen is an Independent Director at TCGX Acquisition Corp.
II and a Co-Chief Executive Officer & Director at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at TCGX Acquisition Corp.
II, Amylyx Pharmaceuticals, Inc. and Practice XYZ LLC.
Mr. Cohen was previously employed as a Founder by Brown Biotechnology Investment Group.
He received his undergraduate degree from Brown University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.09.2026 | 3’613’123 ( 3.27% ) | 105 Mio $ | 30.09.2026 | |
1.2% | 19.10.2026 | 30’000 ( 1.2% ) | 325 800 $ | 30.09.2026 |
Aktive Positionen von Josh Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Gründer | 01.01.2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Josh Cohen
| Unternehmen | Position | Ende |
|---|---|---|
Brown Biotechnology Investment Group | Gründer | - |
Ausbildung von Josh Cohen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Technology Services |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Brown Biotechnology Investment Group |
